BIOMAT Database Logo BIOMAT Database Logo

Identification of carcinoembryonic antigen mRNA in circulating peripheral blood of pancreatic carcinoma and gastric carcinoma patients. 1996

N O Funaki, and J Tanaka, and T Kasamatsu, and G Ohshio, and R Hosotani, and T Okino, and M Imamura
First Department of Surgery, Faculty of Medicine, Kyoto University, Japan.

To detect adenocarcinoma cells in the circulating peripheral blood, we "analyzed the presence of carcinoembryonic antigen (CEA) mRNA in the peripheral blood obtained from patients with pancreatic carcinoma (PC) or with gastric carcinoma (GC) and also, as controls, from pancreatitis or gastritis patients without carcinomas, a gastric lymphoma patient and four healthy volunteers. Because of the small number of carcinoma cells expected in the peripheral blood, the analysis was performed by the reverse transcription followed by an original two-step polymerase chain reaction. By this sensitive method, 3 of 9 PC patients and 2 of 9 GC patients were positive for CEA mRNA. Except for 1 highly advanced PC patient, 3 of 4 CEA mRNA-positive patients developed recurrence after curative resection or liver metastasis after palliative operation within 9 months after the analysis. None of the control patients was positive for CEA mRNA in the peripheral blood. The results suggest that our sensitive RT-PCR method for detecting CEA mRNA in the peripheral blood is practically useful to find the hematogenous spreading of adenocarcinoma cells.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010190 Pancreatic Neoplasms Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA). Cancer of Pancreas,Pancreatic Cancer,Cancer of the Pancreas,Neoplasms, Pancreatic,Pancreas Cancer,Pancreas Neoplasms,Pancreatic Acinar Carcinoma,Pancreatic Carcinoma,Acinar Carcinoma, Pancreatic,Acinar Carcinomas, Pancreatic,Cancer, Pancreas,Cancer, Pancreatic,Cancers, Pancreas,Cancers, Pancreatic,Carcinoma, Pancreatic,Carcinoma, Pancreatic Acinar,Carcinomas, Pancreatic,Carcinomas, Pancreatic Acinar,Neoplasm, Pancreas,Neoplasm, Pancreatic,Neoplasms, Pancreas,Pancreas Cancers,Pancreas Neoplasm,Pancreatic Acinar Carcinomas,Pancreatic Cancers,Pancreatic Carcinomas,Pancreatic Neoplasm
D002272 Carcinoembryonic Antigen A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment. Antigens, CD66e,CD66e Antigen,Antigen, CD66e,Antigen, Carcinoembryonic,CD66e Antigens
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D013274 Stomach Neoplasms Tumors or cancer of the STOMACH. Cancer of Stomach,Gastric Cancer,Gastric Neoplasms,Stomach Cancer,Cancer of the Stomach,Gastric Cancer, Familial Diffuse,Neoplasms, Gastric,Neoplasms, Stomach,Cancer, Gastric,Cancer, Stomach,Cancers, Gastric,Cancers, Stomach,Gastric Cancers,Gastric Neoplasm,Neoplasm, Gastric,Neoplasm, Stomach,Stomach Cancers,Stomach Neoplasm

Related Publications

N O Funaki, and J Tanaka, and T Kasamatsu, and G Ohshio, and R Hosotani, and T Okino, and M Imamura
Circulating carcinoembryonic antigen in pancreatic carcinoma.
September 1978, Cancer,
N O Funaki, and J Tanaka, and T Kasamatsu, and G Ohshio, and R Hosotani, and T Okino, and M Imamura
Carcinoembryonic antigen in patients with gastric carcinoma.
March 1986, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
N O Funaki, and J Tanaka, and T Kasamatsu, and G Ohshio, and R Hosotani, and T Okino, and M Imamura
Carcinoembryonic antigen levels in pancreatic carcinoma.
June 1977, The American surgeon,
N O Funaki, and J Tanaka, and T Kasamatsu, and G Ohshio, and R Hosotani, and T Okino, and M Imamura
Carcinoembryonic antigen mRNA in blood: distinguishing follicular thyroid carcinoma from adenoma.
September 2003, Thyroid : official journal of the American Thyroid Association,
N O Funaki, and J Tanaka, and T Kasamatsu, and G Ohshio, and R Hosotani, and T Okino, and M Imamura
Immunoglobulins, complement and carcinoembryonic antigen in patients with gastric carcinoma.
January 1987, Acta chirurgica Scandinavica. Supplementum,
N O Funaki, and J Tanaka, and T Kasamatsu, and G Ohshio, and R Hosotani, and T Okino, and M Imamura
Carcinoembryonic antigen levels in the peripheral and mesenteric venous blood of patients with rectal carcinoma.
January 2013, Arquivos de gastroenterologia,
N O Funaki, and J Tanaka, and T Kasamatsu, and G Ohshio, and R Hosotani, and T Okino, and M Imamura
Carcinoembryonic antigen levels of portal blood in gastric cancer patients.
July 1989, The Journal of surgical research,
N O Funaki, and J Tanaka, and T Kasamatsu, and G Ohshio, and R Hosotani, and T Okino, and M Imamura
Determination of carcinoembryonic antigen levels in peripheral and draining venous blood in patients with colorectal carcinoma.
January 2004, Arquivos de gastroenterologia,
N O Funaki, and J Tanaka, and T Kasamatsu, and G Ohshio, and R Hosotani, and T Okino, and M Imamura
Identification of carcinoembryonic antigen-producing cells circulating in the blood of patients with colorectal carcinoma by reverse transcriptase polymerase chain reaction.
November 1996, Gut,
N O Funaki, and J Tanaka, and T Kasamatsu, and G Ohshio, and R Hosotani, and T Okino, and M Imamura
Carcinoembryonic antigen (CEA) activity in pancreatic juice of patients with pancreatic carcinoma and pancreatitis.
December 1976, Cancer,
Copied contents to your clipboard!